EPS for Marrone Bio Innovations, Inc. (MBII) Expected At $-0.04

Marrone Bio Innovations, Inc. (NASDAQ:MBII) Logo
Investors sentiment decreased to 0.94 in 2018 Q4. Its down 1.86, from 2.8 in 2018Q3. It worsened, as 6 investors sold Marrone Bio Innovations, Inc. shares while 11 reduced holdings. 8 funds opened positions while 8 raised stakes. 46.51 million shares or 0.40% more from 46.32 million shares in 2018Q3 were reported.
14,333 are owned by Citigroup. Amer Gru owns 35,915 shares. Paloma Prtnrs reported 49,500 shares stake. Spark Investment Ltd Liability Corp holds 0.01% or 64,400 shares in its portfolio. Vanguard Grp Inc invested in 0% or 2.58M shares. Waddell And Reed Financial owns 24.71 million shares or 0.1% of their US portfolio. Bank & Trust Of America De invested in 40,222 shares or 0% of the stock. Citadel Advisors Ltd Liability Corporation stated it has 10,803 shares or 0% of all its holdings. Raymond James Fincl reported 11,061 shares. 2,000 are owned by Carroll Associate Incorporated. State Street reported 911,934 shares or 0% of all its holdings. Fairpointe Lc reported 0.01% of its portfolio in Marrone Bio Innovations, Inc. (NASDAQ:MBII). Geode Capital Mngmt Lc holds 0% or 443,611 shares in its portfolio. California State Teachers Retirement Systems holds 83,489 shares or 0% of its portfolio. State Bank Of Mellon invested 0% in Marrone Bio Innovations, Inc. (NASDAQ:MBII).

Since February 14, 2019, it had 0 buys, and 1 sale for $2.35 million activity.

Analysts expect Marrone Bio Innovations, Inc. (NASDAQ:MBII) to report $-0.04 EPS on May, 9 after the close.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.04 EPS. After having $-0.05 EPS previously, Marrone Bio Innovations, Inc.’s analysts see -20.00 % EPS growth. The stock increased 1.99% or $0.03 during the last trading session, reaching $1.54. About 30,126 shares traded. Marrone Bio Innovations, Inc. (NASDAQ:MBII) has risen 44.14% since May 8, 2018 and is uptrending. It has outperformed by 39.77% the S&P500.

Marrone Bio Innovations, Inc. provides bio pest management and plant health products primarily for agricultural and water markets in the United States and internationally. The company has market cap of $170.50 million. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation. It currently has negative earnings. The company's products include Regalia, a plant extract fungicidal biopesticide for plant disease control and plant health; and Grandevo, a bioinsecticide for insect and mite control to the growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens, and ornamental plants.

More notable recent Marrone Bio Innovations, Inc. (NASDAQ:MBII) news were published by: Globenewswire.com which released: “Marrone Bio Innovations Announces International Distribution Partnership with Agricultural Materials Company (AMC-TR) in Turkey – GlobeNewswire” on November 06, 2018, also Investorplace.com with their article: “3 Stocks to Watch on Monday: Marrone Bio Innovations Inc (MBII), SYNNEX Corporation (SNX) and XCel Brands Inc (XELB) – Investorplace.com” published on April 02, 2018, Globenewswire.com published: “California Cannabis Growers Now Have Access to Safe and Effective Biopesticides From Marrone Bio Innovations – GlobeNewswire” on June 12, 2017. More interesting news about Marrone Bio Innovations, Inc. (NASDAQ:MBII) were released by: Globenewswire.com and their article: “Marrone Bio Innovations to Host Virtual Roadshow Webinar on February 12th at 8:30 a.m. Pacific Time – GlobeNewswire” published on January 29, 2019 as well as Nasdaq.com‘s news article titled: “Marrone Bio Innovations to Report First Quarter 2019 Results on Thursday, May 9th at 4:30 pm Eastern Time – Nasdaq” with publication date: April 25, 2019.

Marrone Bio Innovations, Inc. (NASDAQ:MBII) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.